The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 113: 791-797.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fraker, P. J.
Right arrow Articles by Nisonoff, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fraker, P. J.
Right arrow Articles by Nisonoff, A.

Enhancement of Immunogenicity of a BALB/c Myeloma Protein in BALB/c Mice1

Pamela J. Fraker2, Lucienne Cicurel and Alfred Nisonoff

From the Department of Biological Chemistry, University of Illinois College of Medicine, Chicago, Illinois 60612

Abstract

Antiidiotypic antibodies to the BALB/c myeloma protein, LPC-1 (IgG2a({kappa})) were induced in BALB/c mice by immunization with protein LPC-1 copolymerized with glutaraldehyde to either rabbit IgG or, preferably, C57BL IgG. The copolymers were much more immunogenic than monomeric LPC-1 or polymerized LPC-1. Tests for antibody activity were carried out by using Fab fragments of monomeric LPC-1 as ligand. The use of copolymers as immunogens should facilitate the study of the rejection of myeloma tumors by isologous mice actively producing antiidiotypic antibodies.

When C57BL mice, which differ from BALB/c with respect to heavy chain allotype, were used as recipients, antiidiotypic antibodies were elicited by monomeric LPC-1 as well as by polymers. In CBA mice, which are of the same allotype as BALB/c, monomeric LPC-1 was ineffective but a homopolymer of LPC-1 was an effective immunogen. Since the homopolymer was a very weak immunogen in the BALB/c strain a factor other than known allotypic determinants must play a role. The mechanism of enhancement of immunogenicity by polymerization is discussed.

Footnotes

1 This work was supported by Grant AI-10220 from the National Institutes of Health.

2 Supported by National Institutes of Health Training Grant PHS AI-00335-07.

Present address: Department of Biochemistry, Michigan State University, East Lansing, Michigan 48823.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.